Tus kws kho mob
QP47-22 Medical Drug Management Update – Alpha-1 Proteinase Inhibitors
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 08, 2022
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1981 - 1990 ntawm 4139
Tus kws kho mob
QP48-22 MHCP Pharmacy Benefit Exclusion for Korsuva™ and Leqvio®
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 08, 2022
Tus kws kho mob
QP49-22 Commercial Pharmacy Benefit Exclusion for Carvykti™, Korsuva™, and Leqvio®
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 08, 2022
Tus kws kho mob
QP50-22 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2022
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 08, 2022
Tus kws kho mob
QP51-22 Blue Cross Preferred Genetic Laboratory Program
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 08, 2022
Tus kws kho mob
QP53-22 New Operational Trends Dashboard
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 08, 2022
Tus kws kho mob
upcoming-policies-effective-august-1-2022.pdf